Abstract | Autophagy and apoptosis control the turnover of organelles and proteins within cells, and of cells within organisms, respectively, and many stress pathways sequentially elicit autophagy, and apoptosis within the same cell. Generally autophagy blocks the induction of apoptosis, and apoptosis-associated caspase activation shuts off the autophagic process. However, in special cases, autophagy or autophagy-relevant proteins may help to induce apoptosis or necrosis, and autophagy has been shown to degrade the cytoplasm excessively, leading to 'autophagic cell death'. The dialogue between autophagy and cell death pathways influences the normal clearance of dying cells, as well as immune recognition of dead cell antigens. Therefore, the disruption of the relationship between autophagy and apoptosis has important pathophysiological consequences.
1
. Macroautophagy (hereafter referred to as autophagy) involves the sequestration of portions of the cytoplasm within double-membrane vesicles (autophagosomes), which fuse with lysosomes to form autolysosomes in which autophagic cargo is degraded [2] [3] [4] . This catabolic process, which is mediated by a number of autophagy and autophagy-related proteins
, is primarily used for cellular adaptation to dwindling nutrient resources 5, 6 and is generally considered a protective response. However, in some cases it may also participate in cell death 7, 8 , and it has sometimes been viewed as a separate modality of programmed cell death (PCD) (BOX 3) . As one of the first steps of autophagy is the formation of autophagosomes 9, 10 , its activity is usually assessed on the basis of autophagosome accumulation. Two opposing mechanisms can promote autophagosome accumulation, namely an increase in the rate of autophagosome formation (and hence an increase in autophagic flux) or a decrease in the rate of autophagosome clearance that follows their fusion with lyso somes (and hence a decrease in autophagic flux) 11 , which complicates the interpretation of autophagy assays 12 .
Apoptosis is one of several types of PCD (BOX 2) and is characterized by a series of morphological changes, including nuclear condensation (pyknosis) and fragmentation (karyorrhexis), as well as plasma membrane blebbin g, which lead to the formation of apopt otic bodie s. Apoptosis is accompanied by a sequence of characteristic biochemical changes, including mitochondria l outer membran e permeabilization (MOMP), activation of the effector caspases caspase 3, caspase 6 and caspase 7, and the activation of catabolic hydrolases that degrade most of the macromolecules of the cell, which includes DNA 13 . These morphological and biochemical hallmarks facilitate the detection of apoptosis, although cells that die in vivo are usually engulfed and degraded by healthy cells before they acquire the full apoptotic phenotype, which means that the incidence of apoptosis is usually underestimated 13 . Autophagy and apoptosis often occur in the same cell, mostly in a sequence in which autophagy precedes apoptosis 1 . This is because stress often stimulates an autophagic response, especially if the level of stress is not lethal. Apoptotic and non-apoptotic lethal programmes are activated when stress exceeds a critica l duration or an intensity threshold. In many cases, autophagy constitutes a strategy to adapt to and cope with stress 14 . Nonetheless, if the cell commences apoptosis, autophagy can be in activated, in part owing to the caspase-mediated cleavage of essential autophagy proteins. Beyond this general scenario, in particular circumstances autophagy or essential proteins involved in the autophagic process may promote cellular demise, either by catabolizing indispensable portions of cells or facilitating the activation of apoptotic or necrotic programme s, respectively 13 
.
In this Review, we discuss the complex relationship between autophagy and apoptosis, with a focus on the impact of intersecting signal transduction pathways on the final fate of animal cells in health and disease.
Autophagy precedes apoptosis
Many stimuli that ultimately cause cell death also trigger autophagy. In such cases, autophagy usually manifests well before apoptosis dismantles the cell. Autophagy induction is exacerbated if apoptosis is suppressed, for instance, by removing pro-apoptotic proteins such as BCL-2-associated X protein (BAX) and BCL-2 antagonist or killer (BAK) or by adding caspase inhibitors, including those encoded by viruses 15, 16 . A rapid induction of
Box 1 | Autophagy -the basics
The core autophagy pathway starts with the formation of an isolation membrane (also called a phagophore), most often at the contact sites between mitochondria and the endoplasmic reticulum 111 . However, plasma membranes or other cytoplasmic organelles, including the Golgi, may constitute additional membrane sources for the generation of autophagosomes. As shown in the figure, autophagy involves the spatially and temporarily coordinated activation of multiple molecular components, including the ULK1 (UNC-51-like kinase 1)-FIP200 (FAK family kinase-interacting protein of 200 kDa)-ATG13-ATG101 complex, which is functionally coupled to the negative autophagy regulator, mTOR complex 1 (mTORC1; see the figure, part a), and initiates autophagy; the lipid kinase vacuolar protein sorting 34 (VPS34)-Beclin 1 complex, which is usually inactivated by anti-apoptotic proteins from the BCL-2 family and by other signalling compounds, but when active drives the nucleation of the isolation membrane (see the figure, part b); two transmembrane proteins, ATG9 and vacuole membrane protein 1 (VMP1), which recycle between the Golgi, endosomes and autophagosomes, probably participating in the recruitment of lipids to the isolation membrane (see the figure, part c); two ubiquitin-like (UBL) protein conjugation systems (ATG12 and protein light chain 3 (LC3)) that between them involve one protease (ATG4, which cleaves LC3 at its carboxyl terminus), the E1-like enzyme ATG7 (common to both conjugation systems), and the E2-like enzymes ATG10 (ATG12 system), and ATG3 (LC3 system), which together catalyse the covalent conjugation of ATG12 to ATG5 (which together with ATG16 forms the E3-like ligase of LC3) and that of phosphatidylethanolamine (PE) to LC3 (see the figure, part d);
several SNARE-like proteins that mediate fusion between autophagosomes and lysosomes (see the figure, part e); and various lysosomal enzymes that hydrolyse proteins, lipids and nucleic acids at a low optimum pH 14 (see the figure, part f). Note that LC3 remains associated with autophagosomes and autolysosomes, facilitating their identification.
Most assays for autophagy evaluate the redistribution of LC3 and its homologues (such as GABARAP (GABA receptor-associated protein)) to autophagosomes and autolysosomes by immunohistochemical labelling, or by imaging them in cells after fusion to fluorescent proteins such as GFP. Alternatively, autophagy assays quantify the lipidation of these proteins, which causes an increase in their electrophoretic mobility that is detectable by standard immunoblots 11 . Autophagic cargo is often recognized by the presence of linear Lys63 ubiquitylation, which can tag cargo for uptake by autophagosomes. Organelles or proteins that are marked with Lys63-linked ubiquitin chains interact with a series of adaptors, which possess a LC3-interacting region (LIR) that specifically interacts with LC3-like proteins, thus targeting the cargo to autophagosomes. Such adaptors, which include sequestosome 1 (SQSTM1), are destroyed during autophagy, hence a reduction of their abundance enables an indirect measurement of autophagy 11 . AMPK, AMP-activated protein kinase; BCL-X L , BCL extra large; BH3, BCL-2 homology 3; DEPTOR, DEP domain-containing mTOR-interacting protein; MCL1, myeloid cell leukaemia sequence 1; mLST8, mammalian lethal with SEC13 protein; PRAS40, 40 kDa Pro-rich AKT substrate; RAPTOR, regulatory-associated protein of mTOR. 
Box 2 | Apoptosis and other cell death modalities
The morphological classification of cell death modalities is being progressively replaced by biochemical definitions of the underlying pathways 79 .
Extrinsic apoptosis
This occurs in response to ligation of the so-called death receptors, which are CD95 (also known as FAS), tumour necrosis factor receptor 1 (TNFR1; see the figure, part a) or TNF-related apoptosis-inducing ligand receptor (TRAILR). This results in the recruitment of several proteins, including FAS-associated death domain (FADD), TNFR1-associated death domain (TRADD) and caspase 8. Activated caspase 8 then proteolytically activates downstream effector caspases or truncates the BH3 (BCL-2 homology 3)-only protein BID (BH3-interacting domain death agonist), which co-activates the intrinsic pathway of apoptosis by translocating to mitochondria.
Intrinsic apoptosis
This is marked by one central event -mitochondrial outer membrane permeabilization (MOMP) -which results in the release of cytochrome c from the mitochondrial intermembrane space (see the figure, part b). Cytosolic cytochrome c then triggers the assembly of a caspase-activating complex between caspase 9 and apoptotic protease-activating factor 1 (APAF1; the apoptosome). MOMP can be triggered by the activation of BH3-only proteins following their mobilization from other subcellular compartments and their post-translational modification (such as phosphorylation or proteolysis) or transcriptional upregulation (for instance in response to p53 activation) 34 . BH3-only proteins generally stimulate MOMP by inducing the oligomerization of BCL-2-associated X protein (BAX) and/or BCL-2 antagonist or killer (BAK) in the outer mitochondrial membrane, thereby forming supramolecular channels that mediate the liberation of soluble proteins from the mitochondrial intermembrane space [112] [113] [114] . DNA damage can stimulate the transactivation of genes encoding pro-apoptotic proteins (such as the BH3-only proteins p53 upregulated modulator of apoptosis (PUMA) and NOXA) by p53, or activate caspase 2 in a p53-dependent manner. Caspase 2 may then induce MOMP and/or activate other caspases, such as caspase 3, directly. Among the mitochondrial proteins that are released as a result of MOMP, apoptosis-inducing factor (AIF) and endonuclease G (EndoG) can promote caspase-independent cell death 115 , which can also result from stimuli that cause lysosomal membrane permeabilization (LMP) to release cathepsin proteases into the cytosol 116 . Cathepsins can also trigger MOMP, thereby stimulating the intrinsic apoptotic pathway.
Regulated necrosis
This is often referred to as 'necroptosis' and is a caspase-independent process that involves a series of other effector molecules, including receptor-interacting protein 1 (RIP1) and RIP3 kinases (see the figure, part a) 
117
Mitotic catastrophe
This constitutes an onco-suppressive mechanism that is initiated by disruption of the mitotic apparatus during the M phase of the cell cycle, which is preceded by some degree of mitotic arrest and eventually causes cell death or senescence 118 .
Autophagic cell death
Another cell death modality that, by definition, does not involve apoptotic or necrotic effector molecules, or occurs during mitosis
BAD, BCL-2 antagonist of cell death; DISC, death-inducing signalling complex; JNK, JUN N-terminal kinase; NIX, NIP3-like protein X; ROS, reactive oxygen species.
p53
A central tumour suppressor protein that has multiple functions, both in the cytoplasm and in the nucleus. As a transcription factor, p53 transactivates genes that induce cell cycle arrest, cellular senescence, autophagy and apoptosis.
autophagy, reflecting the instinct of the cell to adapt to stress, is followed by the activation of cell death pathways in response to multiple external signals such as ionizing radiation, chemotherapeutic anticancer agents, the inhibition of growth factor receptors or a scarcity of essential nutrients 17, 18 . The fact that many signal transduction pathways that are elicited by cell-intrinsi c stress regulate both autophagy and apoptosis might explain the sequential activation of both processes. This applies to transcription factors such as p53 and to other key s ignal-transducing molecules, as detailed below.
The p53 protein.
The tumour suppressor protein p53 functions as a signal transduction integrator that is activated by various stressors as diverse as DNA damage, ischaemia-reperfusion and nutrient stress. p53 is usually present in the cytosol but translocates to the nucleus upon DNA damage following its phosphorylation by a number of distinct stress-activated kinases 19 . The available evidence indicates that the cytosolic pool of p53 represses autophagy and that the nuclear translocation of p53 leads to a decrease in this p53 pool, thereby facilitating the induction of autophagy 20 (FIG. 1a) . Cytosolic p53 represses autophagy by interacting with the autophagy protein FIP200 (FAK family kinase-interacting protein of 200 kDa; Atg17 in yeast), thus blocking the activation of the ULK1 (UNC-51-like kinase 1)-FIP200-ATG13-ATG101 complex and inhibiting autophagosome formation 21, 22 
. Moreover, in conditions of cellular stress, a portion of cytosolic p53 can translocate to the mitochondrial matrix, where it interacts with cyclophin D and promotes opening of the permeability transition pore (PTP; a multi protein pore that permeabilizes the inner mitochondrial membrane) 23 . This dissipates the proton gradient that is required for oxidative phosphorylation 24 . At a low intensity, PTP opening can stimulate the autophagic removal of dysfunctional mitochondria 25 . However, PTP opening beyond a critical threshold, which is one of the mechanisms causing MOMP, constitutes a lethal event 24 . Once in the nucleus, p53 transactivates a myriad of genes, influenced by its cofactors and by epigenetic marks (FIG. 1a) . These transcriptional programmes then cause adaptation to stress, cell cycle arrest, autophagy and/ or apoptosis 26 . p53 binds to the promoters of multi ple genes, the protein products of which regulate autophagy, including upstream regulators, such as the β1, β2 and γ-subunits of AMP-activated protein kinase (AMPK), several regulators of the AMPK and mTOR1 complexes, proteins of the autophagy core pathway and lysosomal proteins 27, 28, 29 . Another member of the p53 family, p73, also transactivates proautophagic genes, in particular ATG5 (REF. 30 ). DNA damage-regulated autophagy modulator 1 (DRAM1) exemplifies a p53-induced gene product that stimulates autophagic flux through as yet elusive mechanisms 31, 32 . However, DRAM1 may induce lethal lysosomal membran e permeabilizatio n (LMP) in specific circumstances, for instance in HIV-1 infected CD4 + T cells 33 . In addition, p53 transactivates multiple pro-apoptotic genes, including genes encoding for members of the BCL-2 family such as BAX, BCL-2-interacting mediator of cell death (BIM; also known as BCL2L11) and p53 upregulated modulator of apoptosis (PUMA; also known as BBC3) 34 . BH3-only proteins. Several BH3 (BCL-2 homology 3)-only proteins have the dual capacity to activate autophagy and apoptosis (FIG. 1b) . To induce apoptosis, BH3-only proteins directly interact with multidomain proteins from the BCL-2 family, thereby neutralizing those that have anti-apoptotic roles and stimulating those with pro-apoptotic functions. This gives rise to a complex cascade of reactions that is dictated by the subcellular localization of these proteins, their phosphorylation status and the affinities of each of the p rotein-protein interactions 35 . Several BH3-only proteins, including BAD (BCL-2 antagonist of cell death),
Box 3 | Autophagic cell death
The mere presence of autophagosomes in dying cells, especially if the cytoplasmic volume is not reduced, cannot be interpreted as a sign of autophagic cell death (ACD), and we suspect that many descriptive cases of so-called ACD actually reflect death accompanied by the block of autophagic flux rather than death mediated by autophagy. A strict definition of ACD restricts the use of this term to cell death by autophagy (rather than cell death with autophagy), in which the specific suppression of autophagy prevents cell death and the final cell death process is mediated by enhanced autophagic flux rather than by apoptosis or necroptosis 18, 77, 78, 79 . Much of the evidence in favour of true ACD has been produced in model organisms, including nematodes 119, 120 and the fruitfly Drosophila melanogaster. During D. melanogaster development, a rise in the hormone ecdysone triggers the programmed cell death (PCD) of obsolete larval tissues, including the salivary glands and the midgut, which both sequentially manifest characteristics of autophagy and caspase-dependent apoptosis. The combined inhibition of autophagy (by mutation or knockdown of multiple Atg genes) and caspases blocks salivary gland degradation more efficiently than blockade of either of these processes alone 121, 122 . The suppression of the caspase activation pathway has no effect on midgut removal 123 . By contrast, genetic impairment of autophagy by mutations in either Atg2 or Atg18, or knockdown of either Atg1 or Atg18, delays midgut PCD 123 . Autophagy in the midgut does not require the core E1 and E2 conjugating enzyme-encoding autophagy genes Atg7 and Atg3 (REF. 124 ). Rather, these cells depend on ubiquitin-activating enzyme 1 (Uba1), the E1 enzyme required for ubiquitylation, which operates downstream of Atg1 (UNC-51-like kinase 1 (ULK1) in mammals) 8 . In mammals, evidence for the existence of ACD is scarce, and most reports rely on phenomenological descriptions or the use of nonspecific pharmacological autophagy inhibitors, such as 3-methyladenine or chloroquine. Moreover, the inhibition of cell death achieved by specific manipulations, such as siRNA-mediated depletion of Atg genes, is usually incomplete 125 . However, depletion of ATG5, ATG7 or Beclin 1 can prevent death and restore the clonogenicity of cells that would usually die following overexpression of oncogenic RAS 126, 127 . This observation, which relies on acute RAS overexpression, contrasts with the finding that oncogenic transformation by sustained expression of oncogenic RAS actually requires an intact autophagic machinery 56, 57, 58 . Altogether, the available evidence indicates that ACD does not have an essential role in mammalian development and physiological PCD; however, it may contribute to pathological or drug-induced cell loss. Pyramidal neuronal death in the hippocampus after hypoxia or ischaemia is reduced in mice lacking Atg7 in neurons, but proceeds normally in mice lacking caspase 3 (REF. 128 ). Maladaptive autophagy induced by pressure overload can precipitate cardiac failure, and both autophagy and cardiac dysfunction are avoided by heterozygous disruption of the gene coding for Beclin 1 (REF. 129 ). Knockdown of Atg5 or Becn1, but not the addition of the caspase inhibitor zVAD.fmk or the necroptosis inhibitor necrostatin, can protect mice from otherwise lethal infection by the H5N1 influenza virus 130 . Knockdown of LC3 can reduce the susceptibility of tumour cells to C 18 ceramide-induced growth inhibition in vivo. C 18 ceramide causes dynamin-related protein 1 (DRP1)-dependent mitochondrial fission, as it incorporates into mitochondrial membranes and directly interacts with LC3, thereby stimulating lethal mitophagy 
BCL-2 family
Each member of this protein family contains at least one BCL-2 homology (BH) region. The family is divided into anti-apoptotic multidomain proteins (such as BCL-2, BCL-X L (BCL extra large) and MCL1 (myeloid cell leukaemia sequence 1)), which contain four BH domains (BH1, BH2, BH3 and BH4), pro-apoptotic multidomain proteins (for example, BAX (BCL-2-associated X protein) and BAK (BCL-2 antagonist or killer)), which contain BH1, BH2 and BH3, and the pro-apoptotic BH3-only protein family.
Figure 1 | Signals that induce both apoptosis and autophagy. a | p53. The tumour suppressor p53 exerts both pro-and anti-autophagic functions, which depends on its subcellular localization and activation status. When present in the cytoplasm, p53 inhibits autophagy by interacting with FIP200 (FAK family kinase-interacting protein of 200 kDa) and thus interfering with ULK1 (UNC-51-like kinase 1) complex activity. In response to stress, p53 translocates to the nucleus, where it binds to the promoter region of multiple pro-autophagic genes, including the β1, β2 and γ-subunits of AMP-activated protein kinase (AMPK), damage-regulated autophagy modulator 1 (DRAM1), sestrin 1, sestrin 2 and phosphatase and tensin homologue (PTEN). Nuclear p53 also induces transcription of multiple pro-apoptotic genes. Under certain circumstances, p53 translocates to mitochondria, where it triggers mitochondrial outer membrane permeabilization (MOMP), and thus induces both mitophagy (at first) and apoptosis (when the intensity of the pro-apoptotic stimuli overcomes the protective ability of mitophagy). b | BH3 (BCL-2 homology 3)-only proteins and BH3 mimetics. Through its BH3 domain, Beclin 1 interacts with anti-apoptotic proteins from the BCL-2 family. This inhibits the pro-autophagic function of Beclin 1, but does not interfere with the anti-apoptotic activity of the BCL-2 family proteins. BH3-only proteins, as well as BH3 mimetics, disrupt this interaction, which enables Beclin 1 to increase autophagic activity. One particular BH3-only protein, BCL-2-interacting mediator of cell death (BIM), has a peculiar effect on autophagy. BIM interacts with Beclin 1 and mislocalizes it to dynein light chain 1 (DLC1; not shown), thereby preventing autophagy. Moreover, another BH3-only protein, NIX (NIP3-like protein X), which localizes to mitochondria, favours mitophagy. c | Death associated protein kinase (DAPK). This kinase can stimulate autophagy by phosphorylating Beclin 1, which enables its dissociation from BCL-2 and its association with vacuolar protein sorting 34 (VPS34). DAPK can also activate a second kinase, protein kinase D (PKD), which phosphorylates and activates VPS34. d | JUN N-terminal kinase (JNK). JNK induces autophagy by phosphorylating BCL-2 or BIM, which disrupts their inhibitory interaction with Beclin 1. This leads to an active Beclin 1-VPS34 complex and autophagy and also prevents BCL-2 from inhibiting pro-apoptotic proteins, thus promoting apoptosis. BAD, BCL-2 antagonist of cell death; BCL-X L , BCL extra large; BID, BH3-interacting domain death agonist; PUMA, p53 upregulated modulator of apoptosis.
Unfolded protein response (UPR). The UPR is activated in response to stress in the endoplasmic reticulum (ER). It enables cells to adapt to ER stress by reducing the quantity of misfolded proteins in this organelle.
Senescence
An irreversible G1 cell cycle arrest that is accompanied by morphological changes (flattening of the cells), metabolic alterations and transcriptional reprogramming that leads to the expression of cell cycle blockers, such as p16 and p21, and senescenceassociated ß-galactosidase.
BID (BH3-interacting domain death agonist), BNIP3 (BCL-2 and adenovirus E1B 19 kDa protein-interacting protein 3), NIX (NIP3-like protein X; also known as BNIP3L), NOXA (also known as PMAIP1) and PUMA, can also promote autophagy by competitively disrupting the inhibitory interactions between Beclin 1, one of the central regulators of autophagy, and the antiapoptoti c proteins from the BCL-2 family (BCL-2, BCL-X L (BCL extra large) or MCL1 (myeloid cell leukaemia sequence 1)) (FIG. 1b) . Pharmacological BH3 mimetics elicit a similar effect 36, 37, 38, 39 . The separation of Beclin 1 from BCL-2 or BCL-X L activates the PI3K activity of the autophagy protein vacuolar protein sorting 34 (VPS34), for which Beclin 1 is a necessary co-activator 40 .
In addition, the BH3-only protein NIX may stimulate the selective removal of damaged mitochondria (a process known as mitophagy) by directly interacting with GABA receptor-associated protein (GABARAP), which is a functional homologue of the autophagy protein light chain 3 (LC3; also known as MAP1LC3B) that is present on autophagosomes 41 . Moreover, BIM directly interacts with Beclin 1 and mislocalizes it to dynein light chain 1 (DLC1; also known as DYNLL1), thereby inhibiting Beclin 1 and autophagy activation 42 . Thus, BIM exemplifies a BH3-only protein that induces apopto sis, yet inhibits autophagy. Beyond this exception, it is noteworthy that most of the proteins interacting with Beclin 1 modulate autophagy and apoptosis in the same direction; that is, they inhibit or promote both processes (Supplementary information S1 (table)). It is not entirely clear through which mechanisms BH3-only proteins sequentially stimulate autophagy and apoptosis. One possibility is that BH3-only proteins induce autophagy at low, initial levels of stress by activating the Beclin 1-VPS34 complex, when mitochondria are still protected against lethal permeabilization. However, at a higher, more advanced level of stress, BH3-only proteins would induce MOMP, thereby setting off the apoptotic cascade 43 
Ser/Thr kinases. Ser/Thr kinases, including deathassociate d protein kinase (DAPK), JUN N-terminal kinase (JNK) and AKT (also known as PKB), have also been implicated in the regulation of both autophagy and apoptosis and hence may contribute to the sequential or simultaneous induction of both phenomena. DAPK phosphorylates Beclin 1 within its BH3 domain (at Thr119), which reduces its inhibitory interaction with BCL-2 or BCL-X L (REF. 44 ). Moreover, DAPK can activate protein kinase D (PKD), which then phosphorylates and activates VPS34 (REF. 45 ); in both of these cases, this promotes the induction of autophagy (FIG. 1c) . DAPK also mediates autophagy-independent pro-apoptotic effects 46 , for instance following activation of protein phosphatase 2A (PP2A) when the UNC5H dependence receptor (a receptor that transmits lethal signals when its ligand is absent) is unligated 47 or in the context of c eramide-induced anoikis 48 (a cell death modality caused by detachment of adherent cells from their substrate). JNK can trigger both apoptosis and autophagy by virtue of its capacity to phosphorylate BCL-2 in its flexible loop between the BH4 and BH3 domains (at Thr69, Ser70 and Ser87), which decreases its inhibitory interaction with Beclin 1 and with pro-apoptotic members of the BCL-2 family (FIG. 1d) . Cells that express phosphorylation site mutant variants of BCL-2 are resistant to the induction of autophagy and apoptosis by starvation 43 . In addition, mice bearing such a BCL-2 knock-in phosphorylation mutation are resistant to starvation-and exercise-induced autophagy 49 . JNK also phosphorylates BIM, which leads to the dissociation of BIM and Beclin 1 from DLC1 (REF. 42 ). Another kinase with dual autophagy-apoptosis regulatory potential is AKT. Growth-stimulatory signalling by the PI3K-AKT axis usually represses both autophagy and apoptosis, meaning that inhibition of PI3K or AKT induces both processes. AKT can phosphorylate Beclin 1 and BAD, thus stimulating their inter action with 14-3-3 to inhibit their pro-autophagic and pro-apoptotic functions, respectively 50, 51 . Furthermore, growth factor-mediated activation of AKT represses autophagy by inducing mTOR and repressing the ULK1 complex (Atg1 complex in yeast) 52, 53 . Taken together, this explains why both autophagy and apoptosis are triggered when DAPK or JNK are activated or AKT is inhibited. Again, it seems plausible that cyto protective autophagy is triggered by low levels of kinase-regulated stress, whereas more intense and protracted stress culminate s in apoptotic demise.
Oncogenes.
Oncogenes are an additional example of a stress that induces both autophagy and apoptosis. The sudden activation of the proto-oncogene MYC induces apoptosis in most cells as a tumour-suppressive fail-safe mechanism 54 . Through its stimulatory effect on global translation, MYC activation also elicits an unfolded protein response (UPR), which in turn activates cytoprotective autophagy via the endoplasmic reticulum stress kinase protein kinase RNA-like ER kinase (PERK) to favour cell survival 55 . Whether MYC preferentially induces apoptosis or autophagy-dependent survival is probably determined by the cellular context 55 . When introduced into normal cells, oncogenic H-RAS V12 and K-RAS V12 stimulate autophagy, which is then required for cell survival and oncogenic transformation, presumably because it maintains a functional pool of mitochondria and has other positive bioenergetic effects 56, 57 , or because it enables the cells to prevent cellular senescence 58 . Conversely, in established tumours, the RAS-PI3K-mTOR signalling pathway may suppress autophagy, and inhibition of RAS then stimulates cytoprotective autophagy, limiting the desired death of cancer cells 59 . The molecular circuitries through which abrupt activation of RAS stimulates an autophagic stress response during oncogenic transformation -in contrast to the inhibition of autophagy by the sustained presence of RAS in malignant cellsare not fully understood. Nonetheless, these examples underscore the observation that aberrant homeostasis can stimulate autophagy as an early response that precedes (and often avoids) cell death, even when the same cellular parameter is affected in opposing directions (for example, the activation or inhibition of RAS).
Cytochrome c
A haem protein exclusively present in the mitochondrial intermembrane space. During the initiation of apoptosis, cytochrome c is released from mitochondria and triggers the assembly of the apoptosome, which is a caspase activation complex.
Reactive oxygen species (ROS). Classic oxygen radicals and peroxides that are formed within cells.
Inhibitory crosstalk
Although autophagy and apoptosis are under the control of multiple common upstream signals, these processes also cross-regulate each other, mostly in an inhibitory manner. Thus, autophagy reduces the propensity of cells to undergo apoptosis, and activation of the apoptotic programme is coupled to the suppression of autophagy.
Inhibition of apoptosis by autophagy.
One of the principal mechanisms through which autophagy reduces the tendency of cells to undergo apoptosis is mitophagy 25 . Mitochondria constitute the 'battleground' where survival and death signals converge to determine whether or not intrinsic apoptosis, which is marked by MOMP, is initiated 24 . Indeed, hundreds of distinct factors, including proteins, lipids and metabolites, affect the functional and physical integrity of the two mitochondrial membranes. During cell death, MOMP causes the release of catabolic hydrolases (such as apoptosis-inducing facto r (AIF) and endonuclease G) and caspase activators (such as cytochrome c and SMAC (second mitochondriaderived activator of caspase; also known as DIABLO)) from mitochondria and causes the inner mitochondrial transmembrane potential (Δψ m ) to dissipate, which gives rise to a bioenergetic catastrophe (FIG. 2A) . These changes mark the 'point-of-no-return' during intrinsic apoptosis 24 . Damaged mitochondria are particularly prone to activating the apoptotic programme
, so their removal by autophagy can increase the threshold for apoptosis induction.
How can autophagy selectively target damaged mitochondria for degradation? A reduction in ΔΨ m , which indicates a loss-of-function of the respiratory chain or the permeabilization of the inner membrane, stimulates the Lys63-linked ubiquitylation of proteins anchored in the outer mitochondrial membrane, including voltage-dependent anion-selective channel 1 (VDAC1), mitofusin 1 (MFN1) and MFN2, which tags the organelle for mitophagy. This is possible because dissipation of the ΔΨ m shuts off a protease that usually destroys the kinase PINK1 (PTEN-induced putative kinase 1), causing PINK1 to accumulate at the surface of damage d mitochondria. PINK1 then recruits and phosphorylates PARKIN (Parkinson's disease protein), an E3 ubiquiti n ligase that ubiquitylates substrates in the outer mitochondrial membrane, targeting the organelle for autophagic destruction 25 . In addition to ΔΨ m dissipation, mitochondrial fragmentation through fission is required to cause mitophagy, which constitutes a fail-safe mechanism against the unwarranted removal of functional mitochondria 60 . Mitochondria from starved cells undergo ΔΨ m dissipation but do not fragment, meaning that they do not experience mitophagy 60 . By contrast, mitochondria that undergo opening of the PTP show ΔΨ m dissipation and are fragmented, which enables their removal by autophagy 61 . Autophagy also seems to have a role in the suppression of unwarranted cell death in the pancreas. Pancreatic acinar cells contain inactive enzyme precursors (zymogens), such as trypsinogen (the precursor of trypsin), that are sequestered in granules but may leak into the cytosol to cause cell death. In a model of cerulein-induced pancreatitis, transgenic overexpression of the autophagy-promoting protein vacuole membrane protein 1 (VMP1) stimulated the autophagic removal of granules containing aberrantly activated trypsin 62 . VMP1 overexpression reduces enzymological, histopathological and macroscopic signs of pancreatitis 62 , whereas blocking autophagic flux by depleting VMP1 exacerbates pancreatitis that has been induced by a combination of ethanol and bacterial lipopolysaccharide 63 . Thus, VMP1 promotes the autophagic removal of granule s to prevent cell death.
Autophagy can also attenuate cell death by selectively reducing the abundance of pro-apoptotic proteins in the cytosol (FIG. 2B) . Indeed, autophagy can selectively targe t specific proteins that have been ubiquitylated; this modification enables them to interact with autophagy receptors, a series of adaptors, including sequestosome 1 (SQSTM1; also known as p62), that bind both ubiquitylated substrates and LC3 (REF. 64 ). As an example, colon cancer cells lacking the pro-apoptotic protein BAX are resistant to TRAIL (TNF-related apoptosis-inducing ligand)-induced cell death unless autophagy is inhibited. This is because autophagy mediates the selective removal of active caspase 8 (REF. 65 ). Similarly, in a model of tumour necrosis factor (TNF)-induced hepatocyte apoptosis, inhibition of autophagy by liver-specific knockout of Atg7 increased caspase 8 activity 66 , presumably caused by failed clearance of caspase 8. Moreover, autophagy can target the kinase SRC, thereby enabling cancer cells to avoid anoikis owing to disrupted signalling by focal adhesion kinase (FAK) (FIG. 2C) . In this context, the proto-oncogene Tyr kinase SRC binds to the E3 ubiquitin protein ligase CBL, which possesses an LC3-interacting region that serves as a molecular adaptor to target SRC to LC3-positive phago phores 67 . Finally, autophagy decreases the abundance of SQSTM1, a protein that, if overexpressed, can stimulate the production of reactive oxygen species (ROS) and cell death 68 .
Inhibition of autophagy by apoptosis.
When the intensity or duration of stress reaches the limit of the cell, adaptive mechanisms, including autophagy, are overwhelmed and suicidal cell death programmes are activated. Apoptosis, which is one of the most frequently occurring cell death modalities, is usually accompanied by a high degree of caspase activation
. This results in the cleavage of multiple proteins, which promotes an apoptotic morphology. Caspases can digest several essential autophagy proteins, resulting in the inactivation of the autophagic programme, perhaps with the goal to abort its cytoprotective function and to accelerate cellular demise. Among their targets are ATG3 (REF. 69 ) and Beclin 1 (REF. 70, 71) , the degradation of which leads to the loss of their autophagy-stimulatory function. Moreover, the autophagy protein AMBRA1 (activating molecule in BECN1-regulated autophagy 1) is irreversibly degraded by the combined activity of caspases and calpains, and cells expressing an AMBRA1 mutant lacking the caspase 3 cleavage site are relatively resistant to apoptosis induction 72 . However, it is important to note that, theoretically, Nature Reviews | Molecular Cell Biology cleavage site-mutated proteins could function as pseudosubstrates and hence inhibit the enzymatic activity of caspases 73 , thereby causing difficulties in interpreting experiments in which a mutated protein is expressed at higher levels than its endogenous equivalent. The observed phenotype might result from general caspase inhibition rather than from the suppression of target protein cleavage.
Consistent with a role for the degradation of autophagy proteins in accelerating cell death, several autophagy protein fragments that result from caspase cleavage are thought to acquire pro-apoptotic functions. The cleavage of Beclin 1 by caspase 3, caspase 6 or caspas e 9 results in the generation of a carboxy-termina l fragment, downstream of the BH3 domain, that localizes to mitochondria in cells and permeabilizes isolated mitochondria in vitro to cause the release of cytochrome c 71 . Upon its cleavage by caspase 3, ATG4D also acquires a pro-apoptotic function that may be mediated by a BH3-like domain 74 . On a similar note, the calpainmediated cleavage of ATG5 results in the generation of an amino-terminal fragment that translocates to As caspase 8-induced apoptosis often relies on the cleavage and activation of the BH3-only protein BID (BH3-interacting domain death agonist), which is a potent MOMP inducer, mitophagy may also inhibit lethal signalling via death receptors. C | The selective clearance of the SRC protein by autophagy, which is overactivated in response to disrupted focal adhesion kinase (FAK) signalling, delays the onset of anoikis, which is induced by cell detachment from the extracellular matrix. D,E | Role of autophagy proteins in cell death. Although it generally constitutes a cytoprotective process, autophagosomes or ATG proteins may participate in lethal signalling in some specific circumstances. Da | Autophagosomes may act as platforms for caspase 8 activation, although the precise mechanism (or mechanisms) underlying this event remain poorly understood (indicated by the question mark). Db | In Drosophila melanogaster, the selective autophagy of anti-apoptotic proteins, such as Bruce (BIR-containing ubiquitin-conjugating enzyme; an orthologue of the mammalian inhibitor of apoptosis proteins (IAPs)), contributes to the induction of apoptosis. Dc | Autophagosome accumulation, due to the saturation of the degradative capacity of lysosomes, may facilitate PTP opening and thus lethal MOMP by hitherto unknown mechanisms (indicated by the question mark). Ea | Certain pro-apoptotic stimuli, such as C 6 ceramide or tunicamycin, induce the interaction of ATG12 with anti-apoptotic BCL-2 or MCL1 (myeloid cell leukaemia sequence 1) proteins, thereby inhibiting their function and increasing apoptosis. Eb | ATG7 facilitates lysosomal membrane permeabilization, one of the entry points of the apoptotic pathway, after lysosomal photodamage. DISC, death-inducing signalling complex; PTP, permeability transition pore.
Death receptors
Cell surface receptors that activate the extrinsic pathway of apoptosis upon ligand-induced trimerization. The family of death receptors includes CD95 (which binds CD95 ligand), tumour necrosis factor receptor 1 (TNFR1) and two receptors for TNF-related apoptosis-inducing ligand (TRAILR1 and TRAILR2).
Sphingosine kinase
A conserved lipid kinase that catalyses the formation of the bioactive sphingolipid metabolite sphingosine 1-phosphate. This acts as a second messenger, with important roles in numerous physiological processes, including cell growth, motility and survival. mitochondria and sensitizes cells to apoptosis. This ATG5 fragment also interacts with BCL-X L , although the precise molecular contact points and functional implications of this interaction remain elusive 75 . Nonetheless, these findings suggest that the upregulation of ATG4D, ATG5 and Beclin 1 expression as a result of increased transcription does not only stimulate autophagy but, in addition, generates precursors of proteins that, upon caspas e activation, can accelerate apoptotic demise.
One unique example of the regulation of autophagy by caspases is illustrated by the degradation of BCL-2-associated transcription factor 1 (BCLAF1) by caspase 10 (REF. 76 ). Caspase 10 is an apical caspase that, like caspase 8, can contribute to the induction of apoptosis in response to TNF binding to death receptors. However, in multiple myeloma cells, caspase 10 is constitutively active to degrade BCLAF1, which prevents this molecule from interacting with BCL-2 and competitively disrupting the BCL-2-Beclin 1 complex. Inhibition of caspase 10 causes an uncontrolled increase in autophagic flux that culminates in cell death without the features of apoptosis 76 . This case illustrates the connection between two unusual phenomena -the cytoprotective action of a caspase (because caspase activation usually results in cell death) and excessive, lethal autophagy. Whether this paradigm constitutes an exception or the first example of a new caspase paradox remains to be determined.
Autophagy activates apoptosis
Autophagy can mediate cell death as an effector mechanism, in a process known as autophagic cell death (ACD)
. ACD refers to cell death by autophagy (rather than cell death with autophagy) in which the specific suppression of autophagy by inhibiting, depleting or deleting several distinct essential autophagy genes and/ or proteins prevents cell death; the final cell death process is mediated by autophagy rather than another cell death modality such as apoptosis or necroptosis 18, 77, 78, 79 . However, there are also several examples in which the induction of autophagy facilitates the activation of apoptosis. Moreover, individual proteins that have an essential role in autophagy may have additional roles in pro-apoptotic signalling. In this context, it is important to note that some ATG genes are not exclusively involved in autophagy but are also implicated in various other important cellular processes, including endocytosis and protein secretion 80, 81 . Therefore, it is important to distinguish the function of genes and/or proteins from the process.
Through which mechanisms can autophagy favour the induction of apoptosis? Autophagosome formation, rather than the degradative process, has been implicated in the activation of caspase 8 after treatment of cells with SKI-I, a pan-sphingosine kinase inhibitor, and bortezomib (Velcade; Millennium Pharmaceuticals), a proteasome inhibitor (FIG. 2Da) . In this context, caspase 8 forms a complex with the death receptor adaptor protein FAS-associated death domain (FADD) and ATG5, colocalizes with ATG5, LC3 and SQSTM1, and becomes activated in an ATG5-, FADD-and SQSTM1-dependent manner 82 . In cells treated with SKI-I or bortezomib, inhibition of the early steps of autophagy (by knockout of Atg3 or Atg5) reduced the activation of caspase 8 and that of the effector caspase 3, whereas inhibition of the late steps of autophagy (by bafilomycin A1) increased caspase-dependent cell death 82 . These data indicate that autophagosome formation, rather than the complete process of autophagy, generates a platform for the activation of caspase 8. However, caspase 8 activation usually does not occur when autophagy is induced and liverspecific knockout of ATG7, a protein that acts at early steps of autophagy, can stimulate caspase 8 activation that has been elicited by TNF in vivo 66 . Which factors determine whether autophagosomes can stimulate caspase 8 activation remains elusive.
Autophagy may also stimulate apoptosis by depleting endogenous inhibitors of this cell death pathway. In Drosophila melanogaster, apoptosis is mostly regulated by the interplay between caspases and inhibitor of apoptosis proteins (IAPs). One of these IAPs, Bruce (BIR-containing ubiquitin-conjugating enzyme), is degraded by autophagy, which explains why the genetic inhibition of autophagy (by mutation of atg1, atg13 or vps34) prevents the developmental apoptosis of nurse cells in late oogenesis 83 (FIG. 2Db) .
In addition to stimulating cell death by apoptosis, autophagy can trigger necrosis, a modality of cell death that lacks salient features of apoptosis (such as pyknosis and karyorrhexis) and culminates in early rupture of the plasma membrane 79 . A study carried out in mouse L929 fibrosarcoma cells showed that autophagy can degrade catalase, the enzyme that detoxifies hydrogen peroxide, thereby promoting necrotic cell death 84 (FIG. 2Dc) .
In myocardial ischaemia, autophagy is considered to be cardioprotective, but accumulating autophagosomes can become toxic when the blood supply (and thus oxygen) is restored (known as reperfusion). Indeed, upon reperfusion of hypoxic cardiomyocytes, autophagosomes are formed but fail to be removed. This may be explained by the reduced expression of lysosome-associated membrane protein 2 (LAMP2) as a result of tissue damage; LAMP2 is required for autophagosome-lysosome fusion 85 . Notably, restoring LAMP2 levels synergizes with partial BECN1 (which encodes Beclin 1) knockdown (which reduces, but does not fully block, the formation of autophagosomes) to restore autophagosome processing and to attenuate cell death 86 . When autophagosomes accumulate, cardiomyocytes succumb to a mitochondrial pathway of necrosis, which is blocked by cyclosporin A, an inhibitor of the mitochondrial PTP 86 (FIG. 2Dc) . It remains to be determined through which mechanisms accumulating autophagosomes may stimulate opening of the mitochondrial PTP 86 and hence trigger apoptosis.
ATG proteins may also contribute to lethal signalling independently of the autophagic process. ATG12 is thought to have a role in activating caspases through the mitochondrial pathway
, as its depletion (but not that of other essential ATG proteins) reduces caspas e activation in response to various apoptotic stresses, including C 6 ceramide, etoposide, paclitaxel, staurosporine or tunicamycin (FIG. 2Ea) . This effect involves a BH3 domain in ATG12 that mediates its interaction with BCL-2 and MCL1, as well as its pro-apoptotic function, but is not required for its autophagic activity 87 . Similarly, ATG7 (but not ATG5) facilitates the induction of apoptosis after lysosomal photodamage, presumably by triggering lysosomal membrane permeabilization 88 , which, similarly to MOMP, can trigger apoptosis 89 (FIG. 2Eb) .
These examples illustrate how individual ATG proteins can contribute to lethal signalling.
Intercellular crosstalk
Beyond their crosstalk within the same cell, autophagy and cell death shape the relationship among distinct cells in tissues. For example, soluble products released from necrotic cells may induce autophagy in neighbouring cells. This has been documented for a whole series of danger-associated molecular patterns (DAMPs), such as high mobility group box 1 (HMGB1), S100 proteins and DNA complexes, which act on a series of pattern recognition receptors (PRRs), thereby stimulating autophagy 90, 91 . The abundance of these DAMPs is expected to be particularly high in the context of uncontrolled patho logical death, when necrosis affects vast tissue areas and the clearance of cellular debris is overwhelmed 92 . It is tempting to speculate that the induction of autophagy, which is presumably cytoprotective, by dead cell products can minimize cellular demise adjacent to areas in which cells are dying. Indeed, autophagy has been shown to avoid the loss of cardiomyocytes and neurons in the context of ischaemia 93, 94 . Autophagy occurring in cells before they undergo apoptosis ('pre-mortem autophagy') has a major effect on the fate of dead cells, with regard to their recognition and heterophagy by neighbouring or mobile phagocytic cells. In the context of developmental apoptosis, pre-mortem autophagy is required for the avoidance of inflammation by dead cells 95 (FIG. 3a) . This is because autophagy facilitates the secretion of the chemotactic signal lysophosphatidylcholine (LPC), which mediates the recruitment of phagocytic cells. Autophagy also promotes the cell surface expression of the 'eat-me' signal phosphatidylserine (PtdSer), which facilitates the engulfment of dead cells by phagocytes. When autophagy is inactivated in mouse embryonic tissues, dead cells accumulate and signs of inflammation become apparent 95 . Defective LPC secretion and PtdSer exposure on the surface of dying cells in Atg5 −/− and Becn1 −/− embryoid bodies could be restored by exogenously supplying methylpyruvate, a cell permeable tricarboxylic acid substrate that restores the reduced ATP levels of autophagy-deficient cells 95 . These findings suggest that pre-mortem autophagy may constitute a mechanism to sustain high levels of ATP in cells that undergo developmental apoptosis, thereby facilitating LPC secretion, PtdSer exposure and efficient removal of dead cells, and thereby preventing unwarrante d inflammator y reactions.
In human or mouse cancer cells, pre-mortem autophagy is also required for the release of ATP, which is an important chemotactic signal for phagocytes 96 , from cells that are undergoing apoptosis 97 . This is in part because autophagy maintains high ATP levels in lysosomes and autophagolysosomes, from which ATP is extruded by lysosomal exocytosis 98 . Lysosomal exocytosis involves the fusion of lysosomes with the plasma membrane, through a process that requires LAMP1 (REF. 99 ) and vesicle-associated membrane protein 7 (VAMP7) 100 , and which results in the release of lyso somal content. Although autophagy is dispensable for lysosomal exocytosis, it is required for ATP release from cells through this mechanism 98 . Disabled autophagy in dying cells compromises the immune recognition of deadcell antigens, as documented for both viral antigens 101 and tumour-associated antigens 97 . The failure of dying autophagy-deficient cells to release ATP compromises the recruitment of myeloid and lymphoid cells to the tumour bed after either chemotherapy or radiotherapy, and therefore reduces immunosurveillance 97 (FIG. 3b) . Thus, chemical inhibitors of ecto-ATPases, which are extracellular enzymes that degrade ATP, can increase the ATP concentration in the interstitial fluid and enhance the recruitment of immune cells into the tumour after chemotherapy 97 or radiotherapy 102 . These examples illustrate how pre-mortem autophagy affects the clearance of dead cells in vivo, thereby influencing inflammatory and immune responses 103 .
Concluding remarks and speculations
The mutual relationship between autophagy and apoptosis is highly context-dependent. Beyond rare cases of ACD, in which autophagy truly mediates cell death, there are a few examples in which autophagy or elements of the autophagic machinery may favour the activation of apoptotic or necrotic cell death programmes.
However, in the majority of cases, it seems that apoptosis and autophagy are mutually inhibitory. In most instances, autophagy suppresses apoptosis (or at least raises the threshold of stress required to induce it), which means that autophagy tends to be anti-apoptotic rather than pro-apoptotic. As many cellular stress pathways sequentially induce autophagy (at early time points and low doses of stress) and apoptosis (at late time points and high doses of stress), the overall design of autophagyapoptosis crosstalk reduces the propensity of cells to die (FIG. 4a,b) . In addition, it seems that apoptotic caspase activation degrades essential autophagy proteins, shutting down the autophagic process and converting pro-autophagic proteins into pro-apoptotic ones (FIG. 4c) . This general design of autophagy-apoptosis crosstalk has broad pathophysiological implications.
The mutually negative regulation of autophagy and apoptosis can be expected to increase the contrast between both processes, hence generating a steeper gradient that differentiates non-lethal from lethal stress levels (FIG. 4c) .This may be important in the context of severe tissue damage, for instance, during ischaemia, in which autophagy is induced to limit tissue damage 93, 94 . Ischaemic infarction of tissues is typically characterized by a central necrosis that is surrounded by a penumbra in which both apoptosis and autophagy are detectable. Within this zone, the mutually inhibitory cytoprotective and self-destructive mechanisms may help to delimit the infarcted area. Along the same lines, autophagy induction by soluble products released from dead necrotic cells, or apoptotic cells that have not been cleared, may constitute a strategy to limit tissue damage within the organism.
Usually, especially at low doses of damage (FIG. 4b,c) , the cytoprotective function of autophagy prevails over its potential cytotoxic effects, and autophagy may be considered as one of the mechanisms of hormesis, the phenomenon in which mild, sublethal stress preconditions against the fatal manifestation of a later, normally lethal stress 104 . Thus, autophagy constitutes one of the mechanisms that mediates ischaemic preconditioning, that is, the protection of the heart or the brain against infarction by prior short episodes of sublethal ischaemia 93, 94 . Similarly, autophagy is the mechanism through which chronic mild endoplasmic reticulum stress protects against degenerative diseases of the central nervous system, such as amyotrophic lateral sclerosis (ALS) in mouse models 105 . Although the precise molecular mechanisms through which autophagy mediates hermetic stress and prevents apoptosis or necrosis in these in vivo models have not been addressed, it is tempting to speculate that they involve the same mechanisms as those elucidated in vitro, including the autophagic removal of damaged or degenerating organelles and potentially lethal protein aggregates, hence reducing the propensity of cells to die.
In the context of cancer, autophagy is inhibited by multiple oncogene products (such as PI3K, AKT, BCL-2 and mutant p53), and inhibition of autophagy is a potentially oncogenic event 106 . It has been popular to explain this fact by the failure of autophagy-deficient cancer cell precursors to undergo ACD. Nonetheless, little or no If autophagy inhibits apoptosis, the cell population becomes relatively resistant to cell death, unless the intensity of the stressor overcomes the protective barrier of autophagy. c | Cytoprotective autophagy, followed by lethal subversion of the apoptotic machinery. In this scenario, autophagy would constitute an initial barrier against apoptosis when stress intensity is low (1) . As stress intensity increases (2), the induction of apoptosis results in the subversion of cytoprotective mechanisms, including autophagy, and the conversion of cytoprotective molecules into cytotoxic ones. For example, cleavage of essential ATG proteins does not only inactivate the autophagic machinery but also leads to the generation of protein fragments with novel pro-apoptotic properties. evidence has been produced in favour of this possibility, and alternative explanations must be put forward. In one scenario the suppression of autophagy perturbs cellular metabolism 106 , provokes genome instability (for instance, by the failure to destroy micronuclei containing lagging chromosomes) 107 , interferes with differentiation (owing to the persistence of the midbody remnant, which is usually removed by autophagy) 108 and subverts anticancer immunosurveillance 97 . At late stages of oncogenesis, autophagy is reinstated and increases the resistance of cancer cells to chemotherapy or radiotherapy. Multiple trials using relatively nonspecific autophagy inhibitors, such as chloroquine and hydroxychloroquine, have been launched for the treatment of cancer. It remains to be seen whether these trials will be successful and, if so, whether the anti-neoplastic mode of action of chloroquine derivatives can truly be explained by autophagy inhibition.
Amyotrophic lateral sclerosis (ALS
There is accumulating evidence that ageing is associated with a progressive dysfunction of autophagy, a condition that may favour the accumulation of dysfunctional mitochondria, nuclear genome instability, stem cell attrition, enhanced loss of post-mitotic cells, immunosenescence, unwarranted inflammatory reactions and, in the end, the reduction of hormetic responses that is required for the adaptation to stressful conditions 109 . Moreover, autophagy is induced by, and required for, the positive influences of longevityextending regimens, including caloric restriction, inhibition of insulin and insulin-like growth factor signalling, sirtuin 1 activation or long-term treatments with rapamycin, resveratrol or spermidine 110 . As autophagy is also required for the anti-diabetic effects of physical exercise 49 , it seems that most if not all recommended health-improving behaviours mediate their effects through the induction of autophagy. In this context, it will be interesting to explore ageassociated alterations in the two modes of cellular self-consumption, autophagy and apoptosis, with the scope of gaining mechanistic insights in their functional articulation as well as potential new targets for therapeutic intervention.
